The treatment of leprosy today and tomorrow: the LEPRA consultation on chemotherapy.
作者信息
Browne S G
出版信息
Lepr Rev. 1977 Dec;48(4):283-6. doi: 10.5935/0305-7518.19770034.
PMID:400810
Abstract
摘要
相似文献
1
The treatment of leprosy today and tomorrow: the LEPRA consultation on chemotherapy.
Lepr Rev. 1977 Dec;48(4):283-6. doi: 10.5935/0305-7518.19770034.
2
The chemotherapy of leprosy. Part 1.麻风病的化学疗法。第1部分。
Int J Lepr Other Mycobact Dis. 1990 Dec;58(4):704-16.
3
Dapsone drug resistance in the MDT era.多药联合治疗时代的氨苯砜耐药性。
Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):323-5.
4
The diagnosis and management of dapsone-resistant leprosy.耐氨苯砜麻风病的诊断与管理
Lepr Rev. 1977 Jun;48(2):95-105. doi: 10.5935/0305-7518.19770011.
5
The treatment of leprosy.
Tubercle. 1983 Sep;64(3):221-32. doi: 10.1016/0041-3879(83)90018-1.
6
Recent changes in leprosy control.
Lepr Rev. 1983 Jun;Spec No:7-16. doi: 10.5935/0305-7518.19830044.
7
Leprosy and its chemotherapy.
J Antimicrob Chemother. 1982 Aug;10(2):81-4. doi: 10.1093/jac/10.2.81.
8
Committee 4: workshop on experimental chemotherapy of leprosy.委员会4：麻风病实验化疗研讨会
Int J Lepr Other Mycobact Dis. 1979 Jun;47(2 Suppl):297-303.
9
[Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].[麻风病的抗菌化疗：原则、目标与建议]
Acta Leprol. 1986 Jul-Sep;4(3):355-62.
10
Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.利福平对耐氨苯砜麻风病的长期治疗：临床与细菌学研究
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):159-69.
引用本文的文献
1
Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes.氯法齐明通过干扰T淋巴细胞中的钙振荡来抑制人类Kv1.3钾通道。
PLoS One. 2008;3(12):e4009. doi: 10.1371/journal.pone.0004009. Epub 2008 Dec 23.
Zotero 插件